TP53 and breast cancer: Also, BC patients with positive nodal status, mutated-TP53, basal-like and triple negative BC (TNBC) status had higher AURKA mRNA compared to those with negative-nodal, wild type-TP53, not-basal-like and not-TNBC statuses (Table 3).